SCHEMBL4375391

SCHEMBL4375391

CC(C)(C)C(NC(=O)O)[C@H](Cc1ccccc1F)NC(=O)c1cc(Br)cs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 4/20 0.38
AKT1 P31749 1/20 0.36
AKT2 P31751 1/20 0.36
AKT3 Q9Y243 1/20 0.36
CCR1 P32246 1/20 0.36
CTSS P25774 2/20 0.36
CTSK P43235 1/20 0.36
CHRM1 P11229 1/20 0.35
ANO1 Q5XXA6 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
CTSL P07711 1/20 0.33
ELANE P08246 1/20 0.33
CTSG P08311 1/20 0.33
ELOVL1 Q9BW60 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380618 0.89 ALDH1A1 (0.41) ALDH1A1LMNAHPGDAKT1AKT2
SCHEMBL4374524 0.86 ALDH1A1 (0.47) ALDH1A1LMNAHPGDCCR1SMN1; SMN2
SCHEMBL4583485 0.86 ALDH1A1 (0.47) ALDH1A1LMNAHPGDCCR1SMN1; SMN2
SCHEMBL4373508 0.84 ALDH1A1 (0.42) ALDH1A1LMNAAKT1AKT2AKT3
SCHEMBL4376938 0.84 ALDH1A1 (0.44) ALDH1A1LMNAAKT1AKT2AKT3
SCHEMBL4383634 0.83 ALDH1A1 (0.41) ALDH1A1LMNAAKT1AKT2AKT3
SCHEMBL4373196 0.82 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL4562968 0.81 ALDH1A1 (0.41) ALDH1A1LMNAAKT1AKT2AKT3
SCHEMBL4374076 0.81 ALDH1A1 (0.41) ALDH1A1LMNAAKT1AKT2AKT3
SCHEMBL4371837 0.80 HTR2A (0.40) ALDH1A1LMNAAKT1AKT2AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117523-A1 INHIBITORS OF AKT ACTIVITY SmithKline Beecham Corporation (US) 2009-11-18 EP disclosed
WO-2008098104-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-08-14 WO disclosed